We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.04B
AUM Growth
+$154M
Cap. Flow
-$59.7M
Cap. Flow %
-2.92%
Top 10 Hldgs %
35.2%
Holding
397
New
70
Increased
71
Reduced
131
Closed
34

Top Buys

Rank Stock Value
1
UPS icon
United Parcel Service
UPS
+$27.2M
2
COST icon
Costco
COST
+$26.4M
3
KLAC icon
KLA
KLAC
+$25M
4
IQV icon
IQVIA
IQV
+$23.8M
5
USB icon
US Bancorp
USB
+$23.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$42.7M
2
PG icon
Procter & Gamble
PG
+$33.7M
3
LLY icon
Eli Lilly
LLY
+$32.3M
4
COHR icon
Coherent
COHR
+$22.3M
5
ABT icon
Abbott
ABT
+$21.1M

Sector Composition

Rank Sector Weight
1 Technology 31.29%
2 Consumer Discretionary 14.43%
3 Financials 12.78%
4 Healthcare 12.63%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICE icon
326
Intercontinental Exchange
ICE
$84.5B
$7K ﹤0.01%
63
-12
-16% -$1.38K
OMC icon
327
Omnicom Group
OMC
$23.2B
$7K ﹤0.01%
+93
New +$7.56K
OZK icon
328
Bank OZK
OZK
$5.63B
$7K ﹤0.01%
+175
New +$7.3K
PRU icon
329
Prudential Financial
PRU
$42.1B
$7K ﹤0.01%
+72
New +$7.36K
RARE icon
330
Ultragenyx Pharmaceutical
RARE
$2.64B
$7K ﹤0.01%
70
– –
AON icon
331
Aon
AON
$75.7B
$6K ﹤0.01%
27
-5
-16% -$1.22K
BBIO icon
332
BridgeBio Pharma
BBIO
$16.6B
$6K ﹤0.01%
100
– –
BPMC
333
DELISTED
Blueprint Medicines
BPMC
$6K ﹤0.01%
70
– –
CTVA icon
334
Corteva
CTVA
$51B
$6K ﹤0.01%
+133
New +$6.14K
KMB icon
335
Kimberly-Clark
KMB
$35.9B
$6K ﹤0.01%
47
– –
SANM icon
336
Sanmina
SANM
$10.7B
$6K ﹤0.01%
160
– –
BHVN
337
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$6K ﹤0.01%
60
– –
APLS
338
DELISTED
Apellis Pharmaceuticals
APLS
$5K ﹤0.01%
80
– –
CDNA icon
339
CareDx
CDNA
$2.44B
$5K ﹤0.01%
60
– –
FULC icon
340
Fulcrum Therapeutics
FULC
$286M
$5K ﹤0.01%
+520
New +$5.26K
OSIS icon
341
OSI Systems
OSIS
$3.83B
$5K ﹤0.01%
50
-100
-67% -$9.73K
TGTX icon
342
TG Therapeutics
TGTX
$7.52B
$5K ﹤0.01%
120
– –
TWST icon
343
Twist Bioscience
TWST
$7.83B
$5K ﹤0.01%
+40
New +$4.65K
CAMP
344
DELISTED
CalAmp Corp.
CAMP
$5K ﹤0.01%
+16
New +$4.77K
INSM icon
345
Insmed
INSM
$29.4B
$4K ﹤0.01%
130
– –
NVTA
346
DELISTED
Invitae Corporation
NVTA
$4K ﹤0.01%
130
– –
VIVO
347
DELISTED
Meridian Bioscience Inc
VIVO
$4K ﹤0.01%
180
-300
-63% -$6.36K
ALLK
348
DELISTED
Allakos
ALLK
$3K ﹤0.01%
30
– –
EBS icon
349
Emergent Biosolutions
EBS
$229M
$3K ﹤0.01%
50
– –
FOLD
350
DELISTED
Amicus Therapeutics
FOLD
$3K ﹤0.01%
300
– –
12 13
14
15 16

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Smith Group Asset Management held 397 positions worth $2.04B, up 8.2% from $1.89B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Smith Group Asset Management's Q2 2021 filing shows 70 new, 71 increased, 131 reduced and 34 closed positions. Its largest new stake was KLA: 780,720 shares worth $25.3M. The largest sale was Hologic, an estimated $42.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Smith Group Asset Management's largest Q2 2021 buy was KLA: 780,720 shares worth $25.3M.
  • Smith Group Asset Management added most to United Parcel Service in Q2 2021, an estimated $27.2M increase.
  • Smith Group Asset Management's biggest Q2 2021 reduction was Procter & Gamble, cutting an estimated $33.7M.
  • Smith Group Asset Management fully exited Hologic in Q2 2021, selling an estimated $42.7M.
  • Smith Group Asset Management's ten largest holdings make up 35% of its $2.04B portfolio in Q2 2021.
  • Smith Group Asset Management opened 70 new positions and closed 34 in Q2 2021.
  • Smith Group Asset Management's portfolio value rose 8.2% quarter-over-quarter to $2.04B.

Based on Smith Group Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.